Showing results (1161-1170 of 1,611) with videos related to

Sort By:
Pageof 162
JAMA Oncology|November 9, 2023
Implications of High Tumor Burden on Chimeric Antigen Receptor T-Cell Immunotherapy: A ReviewMarco Ventin, Giulia Cattaneo, Luke Maggs, et al.
JAMA Oncology|November 4, 2023
Diagnostic Outcomes of Concurrent DNA and RNA Sequencing in Individuals Undergoing Hereditary Cancer TestingCarolyn Horton, Lily Hoang, Heather Zimmermann, et al.
JAMA Oncology|October 5, 2023
Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Phase 3 Randomized Clinical TrialShukui Qin, Masatoshi Kudo, Tim Meyer, et al.
JAMA Oncology|October 12, 2023
Toll-Like Receptor 4 Agonist Injection With Concurrent Radiotherapy in Patients With Metastatic Soft Tissue Sarcoma: A Phase 1 Nonrandomized Controlled TrialYongwoo David Seo, Hailing Lu, Graeme Black, et al.
JAMA Oncology|July 20, 2023
Association of Reducing the Recommended Colorectal Cancer Screening Age With Cancer Incidence, Mortality, and Costs in Canada Using OncoSimAnastasia Kalyta, Yibing Ruan, Jennifer J Telford, et al.
JAMA Oncology|July 13, 2023
Management of Down Syndrome-Associated Leukemias: A ReviewAnupam Verma, Philip J Lupo, Nirali N Shah, et al.
JAMA Oncology|August 24, 2023
Assessment of Artificial Intelligence Chatbot Responses to Top Searched Queries About CancerAlexander Pan, David Musheyev, Daniel Bockelman, et al.
JAMA Oncology|September 7, 2023
Neoadjuvant Immune Checkpoint Inhibitor Therapy for Localized Deficient Mismatch Repair Colorectal Cancer: A ReviewOluwadunni E Emiloju, Frank A Sinicrope
JAMA Oncology|September 28, 2023
Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors: A Phase 1a/1b Nonrandomized Controlled TrialTae Won Kim, Philippe L Bedard, Patricia LoRusso, et al.
JAMA Oncology|June 29, 2023
US Cancer Mortality Trends Among Hispanic Populations From 1999 to 2020Isabella R Pompa, Anushka Ghosh, Shamik Bhat, et al.
Pageof 162